A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
Authors:
- Harvey I. PassHPHarvey I. Pass
- George J. BrewerGBGeorge J. Brewer
- Robert DickRDRobert Dick
- Michele CarboneMCMichele Carbone
- Sofia MerajverSMSofia Merajver
- 1 August 2008
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 86 (2) , 383-390
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural MesotheliomaThe Annals of Thoracic Surgery, 2007
- Eighth International Mesothelioma Interest GroupOncogene, 2007
- Emerging drugs for mesotheliomaExpert Opinion on Emerging Drugs, 2007
- Interleukin‐6 induces both cell growth and VEGF production in malignant mesotheliomasInternational Journal of Cancer, 2006
- Phase I to II Study of Pleurectomy/Decortication and Intraoperative Intracavitary Hyperthermic Cisplatin Lavage for MesotheliomaJournal of Clinical Oncology, 2006
- Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experienceLung Cancer, 2005
- Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma: Is It Safe?Journal of Clinical Oncology, 2005
- The effect of extent of local resection on patterns of disease progression in malignant pleural mesotheliomaThe Annals of Thoracic Surgery, 2004
- Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatmentsCritical Reviews in Oncology/Hematology, 2004
- A proposed new International TNM Staging System for malignant pleural mesothelioma from the International Mesothelioma Interest GroupLung Cancer, 1996